Latest Reimbursement News

Page 1 of 50
Nuix has given Haveli five weeks of exclusive access to pursue a potential A$2.75-per-share cash takeover, valuing certainty at a substantial premium to the market price. The proposal is still non-binding, but the board intends to recommend it if Haveli delivers a binding offer on at least those terms.
Sophie Babbage
Sophie Babbage
18 Nov 2026
Epiminder has signed a five-year rolling partnership with Stratus Neuro to integrate its long-term Minder EEG data into StratusEEG, a cloud platform used by more than 7,000 US clinicians and administrators. The agreement gives Epiminder an established clinical workflow for its DETECT study and planned US commercialisation, although no financial terms or launch date were disclosed.
Victor Sage
Victor Sage
17 Nov 2026
Ingenia Communities has opened a non-exclusive bidding process with AVID Property Group and Warburg Pincus after AVID matched a $5.55 cash offer plus a potential $0.05 distribution. The company is still pursuing its Peet acquisition after the ACCC allowed the transaction and Flagstone joint venture to proceed, subject to a review window.
Eva Park
Eva Park
16 Nov 2026
Nova Minerals has cleared the final regulatory hurdle for its Alaska antimony pilot project, but the milestone arrives alongside a US$12.0 million quarterly loss and a warning that existing resources may not fund planned operations for 12 months. The company is targeting 2027 pilot-scale production while relying on further government reimbursements and new capital.
Maxwell Dee
Maxwell Dee
16 Nov 2026
Sarama Resources posted a US$2.27 million nine-month profit after selling its Western Australian gold projects, but the gain was largely accounting-based and management says further funding is required. Cash stood at US$619,667 as the company advances a US$245.3 million Burkina Faso arbitration claim.
Maxwell Dee
Maxwell Dee
13 Nov 2026
Ingenia has opened a new round in its takeover contest after receiving a non-exclusive Warburg Pincus proposal worth $5.55 cash per stapled security, plus a possible distribution of up to $0.05. AVID now has until 15 November to match or improve it, while Ingenia continues to pursue its proposed Peet acquisition.
Eva Park
Eva Park
13 Nov 2026
Anteris Technologies reported a wider third-quarter loss as spending accelerated on its PARADIGM heart-valve trial and manufacturing expansion. The company ended September with US$236.3 million in cash, but also retained unresolved weaknesses in financial reporting controls.
Ada Torres
Ada Torres
11 Nov 2026
Maritana Minerals has committed a further A$19.9 million to keep Black Swan Processing Hub works moving while its EPC contract is finalised. Concrete is now being placed for the new CIL circuit, with first gold still targeted for the second half of 2027.
Maxwell Dee
Maxwell Dee
11 Nov 2026
EBR Systems delivered higher reimbursement, manufacturing and revenue milestones in the third quarter, but a sharp September slowdown and a formal going-concern warning have shifted attention to execution and funding. The company says it holds US$93.2 million in cash, cash equivalents and marketable securities, while US$41.8 million of debt falls due within 12 months.
Victor Sage
Victor Sage
10 Nov 2026
PPL has raised its long-term earnings growth target and unveiled a US$25 billion investment plan, while positioning new generation projects to capture soaring data centre demand. The opportunity is substantial, but the headline Pennsylvania deal remains non-binding and the plan requires further equity funding.
Maxwell Dee
Maxwell Dee
6 Nov 2026
US Medicare has set a national outpatient payment of US$31,265 for Epiminder’s Minder System implant procedure from 1 January 2027, up 13% on the 2026 rate. The decision gives hospitals a defined reimbursement benchmark ahead of Epiminder’s planned US commercial launch.
Ada Torres
Ada Torres
6 Nov 2026
AVITA Medical has raised its 2026 revenue guidance for a second time after third-quarter revenue climbed 53% year on year. The company also drew a further US$10 million under its credit facility and removed its going-concern qualification, although it remains loss-making and highly leveraged.
Victor Sage
Victor Sage
6 Nov 2026

Browse the archive

Full archive